Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Alimentary Pharmacology & Therapeutics
|
October 2, 2024
Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients
Max S Schechter, Linnea Widman, Axel Wester, et al.
European Journal of Internal Medicine
|
February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study
Joost Boeckmans, Linnea Widman, Ying Shang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 2, 2024
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
Patrik Nasr, Ying Shang, Axel Wester, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 28, 2023
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study
Fahim Ebrahimi, Tracey G Simon, Hannes Hagström, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 18, 2024
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Patrik Nasr, Axel Wester, Mattias Ekstedt, et al.
Open Heart
|
September 30, 2020
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
Rubina Attar, Axel Wester, Sasha Koul, et al.
Circulation. Cardiovascular Interventions
|
March 29, 2020
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
Axel Wester, Rubina Attar, Moman A Mohammad, et al.
Journal of Hepatology
|
April 14, 2025
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
Juan Vaz, Patrik Nasr, Anders Helander, et al.
Journal of the American Heart Association
|
August 8, 2019
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial
Axel Wester, Rubina Attar, Moman Aladdin Mohammad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 27, 2022
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Alimentary Pharmacology & Therapeutics
|
October 2, 2024
Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients
Max S Schechter, Linnea Widman, Axel Wester, et al.
European Journal of Internal Medicine
|
February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study
Joost Boeckmans, Linnea Widman, Ying Shang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 2, 2024
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
Patrik Nasr, Ying Shang, Axel Wester, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 28, 2023
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study
Fahim Ebrahimi, Tracey G Simon, Hannes Hagström, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 18, 2024
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Patrik Nasr, Axel Wester, Mattias Ekstedt, et al.
Open Heart
|
September 30, 2020
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
Rubina Attar, Axel Wester, Sasha Koul, et al.
Circulation. Cardiovascular Interventions
|
March 29, 2020
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
Axel Wester, Rubina Attar, Moman A Mohammad, et al.
Journal of Hepatology
|
April 14, 2025
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
Juan Vaz, Patrik Nasr, Anders Helander, et al.
Journal of the American Heart Association
|
August 8, 2019
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial
Axel Wester, Rubina Attar, Moman Aladdin Mohammad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 27, 2022
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, et al.
Page
of 5